Landscape Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Landscape Capital Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-66,744	Closed	-$524K	–	883
2015 Q4	$524K	Buy	+66,744	New	+$575K	0.07%	446
2015 Q2	–	Sell	-19,485	Closed	-$272K	–	787
2015 Q1	$272K	Buy	+19,485	New	+$298K	0.07%	379
2014 Q1	–	Sell	-39,800	Closed	-$550K	–	220
2013 Q4	$550K	Buy	+39,800	New	+$562K	0.51%	36

Other funds holding INFI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Landscape Capital Management's INFI Position: Q1 2016 in Review

Landscape Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2016, closing a stake of 66,744 shares — an estimated $524K sold.

Landscape Capital Management first reported a position in INFI in Q4 2013 and held it in 3 quarters. The position peaked at $550K in Q4 2013. 117 funds tracked by Wall St. Rank hold INFI as of Q1 2016.

Landscape Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Landscape Capital Management sold 66,744 Infinity Pharmaceuticals, Inc. shares in Q1 2016, an estimated $524K.
Landscape Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2013 and held it in 3 quarters.
Landscape Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $550K in Q4 2013.
117 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2016.

Based on Landscape Capital Management's 13F filing for Q1 2016, filed 11 May 2016.